Clinical Outcome of Implants Placed in Grafted Maxillary Sinus Using Recombinant Human Bone Morphogenetic Protein-2: A 5-year Follow-Up Study
10.5856/JKDS.2024.17.1.45
- Author:
Yu-Jeong BAEK
1
;
Jin-Ho LEE
;
Hyo-Jeong KIM
;
Bok-Joo KIM
;
Jang-Ho SON
Author Information
1. Department of Oral and Maxillofacial Surgery, University of Ulsan Hospital, University of Ulsan College of Medicine, Ulsan, Korea
- Publication Type:ORIGINAL ARTICLE
- From:Journal of Korean Dental Science
2024;17(1):45-52
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:To investigate the 5-year outcome of dental implants placed in a grafted maxillary sinus using recombinant human bone morphogenetic protein-2 (rhBMP-2).
Materials and Methods:We retrospectively analyzed 27 implants after maxillary sinus floor augmentation (MSFA) using rhBMP-2 in 16 patients between January 2016 and March 2017. The study evaluated two outcome variables: (1) 5-year cumulative survival and success rate of the implant after functional loading and (2) marginal bone loss (MBL) for implant failure.
Results:The average residual bone height was 4.78±1.53 mm. The healing period before loading was 8.35±2.34 months. The crown-to-implant ratio was 1.31±0.26. The 5-year cumulative survival and success rate after functional loading were 100% and 96.3%, respectively. The 5-year average MLB was 0.89±0.82 mm.
Conclusion:Placing dental implants with MSFA using rhBMP-2 is a reliable procedure with favorable long-term survival and success rates.
